Author:
Javitt Daniel C.,Buchanan Robert W.,Keefe Richard S.E.,Kern Robert,McMahon Robert P.,Green Michael F.,Lieberman Jeffrey,Goff Donald C.,Csernansky John G.,McEvoy Joseph P.,Jarskog Fred,Seidman Larry J.,Gold James M.,Kimhy David,Nolan Karen S.,Barch Deanna S.,Ball M. Patricia,Robinson James,Marder Stephen R.
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference36 articles.
1. Specificity of the Calgary Depression Scale for schizophrenics;Addington;Schizophr. Res.,1994
2. The Scale for the Assessment of Negative Symptoms (SANS);Andreasen,1984
3. Grey matter and cognitive deficits in young relatives of schizophrenia patients;Bhojraj;Neuroimage,2011
4. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia;Buchanan;Biol. Psychiatry,2011
5. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5years later?;Buchanan;Schizophr. Bull.,2010
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献